Effect of 2016 FDA guidance on study population and clinical response rates in patients with bacterial vaginosis: a phase 3 post hoc analysis

Journal Title: Clinical and Experimental Obstetrics & Gynecology - Year 2019, Vol 46, Issue 4

Abstract

Summary Purpose of Investigation: In 2016, the US Food and Drug Administration updated the enrollment and clinical response criteria for clinical studies of bacterial vaginosis (BV). The purpose of this post hoc analysis was to determine the effects of these differences on the results of a previously published phase 3 clinical study of the use of a single oral dose of secnidazole 2 grams to treat BV. Results: The updated guidelines for enrollment include a more stringent baseline Nugent score cutoff, which reduced the number of subjects from the initial study by 16.8% (secnidazole group) and 7.0% (placebo group). The updated efficacy guidelines changed the clinical outcome responder rates to 64.0% (secnidazole) and 26.4% (placebo) on assessment days 7–14 (p < 0.001), and to 58.4% and 24.5%, respectively, on days 21–30 (p < 0.001). Conclusion: Although the guidelines did not significantly affect efficacy outcomes, future BV studies will need to screen more patients to compensate for the new, more stringent enrollment criteria.

Authors and Affiliations

P. Nyirjesy, M. Padula, J. L. Amprey

Keywords

Related Articles

A case of recurrent posterior reversible encephalopathy syndrome

Purpose: To report a case of recurrent posterior reversible encephalopathy syndrome (PRES) after post-partum eclampsia. Case Report: A 22-year-old woman, para 3+0, presented with headaches, decrease level of consciousnes...

The role of obesity and environmental factors such as diet and physical activity in the etiopathogenesis of fertility disorders

The most common causes affecting female reproductive potential in Poland are anovulatory cycles, diseases of the fallopian tubes and the peritoneum, male factor, and pathological changes of the uterus. It was observed th...

Two cases of uterine and vaginal malformations

Objective: To evaluate the efficacy of hysteroscopy and laparoscopy for oblique uterine septum and oblique vaginal septum. Case Report: There were one patient with oblique uterine septum and another patient with oblique...

Monitoring and assessing pre-labor obstetric practicesc using control charts: cesarean delivery cases

Due to the increase of the cesarean delivery rates globally, several researchers focused their attention on the analyses and monitoring of these rates. Present research focuses on analyzing cesarean delivery rates from t...

Influence of route of delivery on perinatal outcomes in fetuses with myelomeningocele

The optimal route of delivery of fetuses with myelomeningocele is controversial. The aim of this study is to determine whether route of delivery predisposes to perinatal complications and influences short-term outcomes i...

Download PDF file
  • EP ID EP673404
  • DOI 10.12891/ceog4892.2019
  • Views 72
  • Downloads 0

How To Cite

P. Nyirjesy, M. Padula, J. L. Amprey (2019). Effect of 2016 FDA guidance on study population and clinical response rates in patients with bacterial vaginosis: a phase 3 post hoc analysis. Clinical and Experimental Obstetrics & Gynecology, 46(4), 615-617. https://europub.co.uk/articles/-A-673404